Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Urology. 2013 Jul;82(1):53–58. doi: 10.1016/j.urology.2012.10.090

Table 2.

Ability of various postoperative nomograms to predict biochemical recurrence and prostate cancer-specific mortality (n = 1778)

BCR PCSM
Nomogram HR 95% CI P Value c-index HR 95% CI P Value c-index
DPC 2.74 2.50–3.01 <.001 0.75 2.81 1.90–4.14 <.001 0.83
Kattan postoperative 2.02 1.89–2.16 <.001 0.74 2.57 1.92–3.45 <.001 0.86
JHH 2.09 1.93–2.24 <.001 0.74 2.97 2.12–4.18 <.001 0.87
CPDR/CaPSURE 1.09 1.07–1.10 <.001 0.72 1.10 1.07–1.14 <.001 0.82

BCR, biochemical recurrence; CI, confidence interval; CPDR/CaPSURE, joint Center for Prostate Disease Research/Cancer of the Prostate Strategic Urologic Research Endeavor; DPC, Duke Prostate Center; HR, hazard ratio; JHH, Johns Hopkins Hospital; PCSM, prostate cancer-specific mortality.